Melatonin and Sleep Regulation

Melatonin: The Basics - Pineal's Pacemaker

• Melatonin: A key neurohormone, often dubbed the 'hormone of darkness' due to its nocturnal secretion pattern.
• Primary Source: Synthesized and secreted mainly by the pineal gland; also found in retina, gut.
• Regulation: Production significantly increases (↑) in darkness and decreases (↓) with light exposure.
  • Light detected by retinal ganglion cells inhibits release via the retinohypothalamic tract to the SCN.
• Function: Acts as a potent chronobiotic, crucial for entraining the circadian rhythm (the body's ~24-hour sleep-wake cycle).
• Master Control: The suprachiasmatic nucleus (SCN) in the hypothalamus is the principal circadian pacemaker, orchestrating melatonin release.

  ⭐ Melatonin secretion is primarily controlled by the SCN, the master circadian pacemaker, located in the hypothalamus.

Melatonin: Synthesis & Cycle - Night's Elixir

• Synthesis Pathway: Begins with Tryptophan.
  • Tryptophan $\rightarrow$ 5-Hydroxytryptophan $\rightarrow$ Serotonin $\rightarrow$ N-Acetylserotonin (NAS) $\rightarrow$ Melatonin.
  • 📌 Mnemonic for key steps: Try Some New Apples (Tryptophan, Serotonin, N-Acetylserotonin, Melatonin).
• Key Enzymes in Synthesis:
  • AANAT (Arylalkylamine N-acetyltransferase): Converts Serotonin to NAS. Rate-limiting.
  • HIOMT/ASMT (Hydroxyindole-O-methyltransferase): Converts NAS to Melatonin.

• Regulation by Light-Dark Cycle:
  • Light (via Retinohypothalamic Tract, RHT to Suprachiasmatic Nucleus, SCN) $\rightarrow$ $\downarrow$ Melatonin.
  • Darkness $\rightarrow$ SCN disinhibition $\rightarrow$ Superior Cervical Ganglion (SCG) releases Norepinephrine $\rightarrow$ $\uparrow$ Melatonin from pineal gland.

⭐ Arylalkylamine N-acetyltransferase (AANAT) is the rate-limiting enzyme in melatonin synthesis, and its activity is dramatically $\uparrow$ during darkness and suppressed by light.

Melatonin: Receptors & MOA - Switch to Slumber

• Acts via G-protein coupled receptors (GPCRs):
  • MT1 Receptors (SCN):
    • ↓ SCN neuronal activity → promotes sleep.
    • ↓ Body temperature.
    • 📌 MT1 = Sleepy Time 1.
  • MT2 Receptors (SCN, retina):
    • Phase-shifts circadian rhythms (advancing/delaying).
    • Influences sleep timing.
    • 📌 MT2 = Time Zone 2.
  • MT3 Receptors: Enzyme quinone reductase 2; role in sleep less clear.
• MOA:
  • Binding MT1/MT2 in SCN → inhibits adenylyl cyclase → ↓ cAMP → ↓ neuronal firing.
  • Effects: ↑ sleep propensity, circadian rhythm synchronization.

⭐ MT1 activation primarily mediates sleep promotion by inhibiting SCN neuronal activity; MT2 activation is crucial for phase-shifting circadian rhythms.

Melatonin: Clinical Uses - Timing is Everything

• Jet Lag: Effective when taken close to target bedtime at destination. Dose: 0.5-5 mg.
• Shift Work Sleep Disorder (SWSD): May improve daytime sleep length and quality.
• Delayed Sleep-Wake Phase Disorder (DSWPD): Advances sleep onset; low dose hours before desired bedtime.
• Non-24-Hour Sleep-Wake Disorder: Primarily in blind individuals; helps entrain to a 24-hour cycle.
• Insomnia: Particularly for sleep-onset difficulties.
  • Melatonin Agonists:
    • Ramelteon: Selective MT1/MT2 agonist. Dose: 8 mg.

      ⭐ Ramelteon, a selective MT1/MT2 agonist, is approved for insomnia characterized by difficulty with sleep onset and, unlike benzodiazepines, lacks significant abuse potential or withdrawal effects.

    • Tasimelteon: For non-24-hour sleep-wake disorder.
    • Agomelatine: Antidepressant with MT1/MT2 agonistic properties.
• Other Potential Uses:
  • Antioxidant properties.
  • Immune modulation.

High‑Yield Points - ⚡ Biggest Takeaways

• Melatonin from pineal gland regulates circadian rhythm & sleep onset.
• Synthesized from tryptophan via serotonin; release stimulated by darkness, inhibited by light.
• Suprachiasmatic Nucleus (SCN) is the master circadian pacemaker, controlling melatonin secretion.
• Melatonin levels peak mid-night, facilitating sleep maintenance and body temperature drop.
• Acts via G-protein coupled MT1 and MT2 receptors, primarily in the SCN.
• Clinically used for jet lag, insomnia, delayed sleep-wake phase disorder, and shift work disorder.